Wednesday, 25 January 2023
Print
| DAY 1 | Panoramazaal | DAY 1 |
| DAY 1 | Panoramazaal | DAY 1 |
| 10:00 | Registration & Coffee | 10:00 |
| 10:05 | 10:05 | |
| 10:10 | 10:10 | |
| 10:15 | 10:15 | |
| 10:20 | 10:20 | |
| 10:25 | 10:25 | |
| 10:30 | 10:30 | |
| 10:35 | 10:35 | |
| 10:40 | 10:40 | |
| 10:45 | Event Welcome & ELRIG Introduction 10:45 (5 mins) Site Welcome to Pivot Park 10:50 (10 mins) Brigitte Drees, Pivot Park Session Introduction 11:00 (5 mins) Saman Honarnejad, Pivot Park Screening Centre Cell-based MALDI MS assays for the characterization of enzymatic reactions and transporter uptake 11:05 (20 mins) Sandra Schulz, CeMOS |
10:45 |
| 10:50 | 10:50 | |
| 10:55 | 10:55 | |
| 11:00 | 11:00 | |
| 11:05 | 11:05 | |
| 11:10 | 11:10 | |
| 11:15 | 11:15 | |
| 11:20 | 11:20 | |
| 11:25 | Refreshment Break | 11:25 |
| 11:30 | 11:30 | |
| 11:35 | 11:35 | |
| 11:40 | 11:40 | |
| 11:45 | 11:45 | |
| 11:50 | Unbiased high-throughput MALDI-TOF MS screening assays in primary human cells for drug discovery 11:50 (20 mins) Maria Emilia Dueñas, Newcastle University Perspectives of MALDI MS cell assays – from phenotypic screening to miniaturized assays on droplet microarrays. 12:10 (20 mins) Carsten Hopf, CeMOS Panel Discussion with Q&A 12:30 (20 mins) Saman Honarnejad, Pivot Park Screening Centre |
11:50 |
| 11:55 | 11:55 | |
| 12:00 | 12:00 | |
| 12:05 | 12:05 | |
| 12:10 | 12:10 | |
| 12:15 | 12:15 | |
| 12:20 | 12:20 | |
| 12:25 | 12:25 | |
| 12:30 | 12:30 | |
| 12:35 | 12:35 | |
| 12:40 | 12:40 | |
| 12:45 | 12:45 | |
| 12:50 | Refreshment Break | 12:50 |
| 12:55 | 12:55 | |
| 13:00 | 13:00 | |
| 13:05 | 13:05 | |
| 13:10 | 13:10 | |
| 13:15 | 13:15 | |
| 13:20 | 13:20 | |
| 13:25 | 13:25 | |
| 13:30 | 13:30 | |
| 13:35 | 13:35 | |
| 13:40 | 13:40 | |
| 13:45 | 13:45 | |
| 13:50 | 13:50 | |
| 13:55 | 13:55 | |
| 14:00 | Session Introduction 14:00 (5 mins) Jarrod Walsh, AstraZeneca Evaluating target engagement of drug-like and pan-assay interfering compounds using ASMS 14:05 (20 mins) Fleur Kleinpenning, Pivot Park Screening Centre Getting around bottlenecks in AS-MS: an LC/HRMS perspective 14:25 (20 mins) Carole Reymond, EDELRIS |
14:00 |
| 14:05 | 14:05 | |
| 14:10 | 14:10 | |
| 14:15 | 14:15 | |
| 14:20 | 14:20 | |
| 14:25 | 14:25 | |
| 14:30 | 14:30 | |
| 14:35 | 14:35 | |
| 14:40 | 14:40 | |
| 14:45 | Refreshment Break | 14:45 |
| 14:50 | 14:50 | |
| 14:55 | 14:55 | |
| 15:00 | From analyzing purified targets to cells: Combining surface chemistry and MALDI MS to analyze biochemical and binding reactions 15:00 (20 mins) Zachary Gurard-Levin, SAMDI Tech, Inc. Panel Discussion with Q&A 15:20 (20 mins) Jarrod Walsh, AstraZeneca |
15:00 |
| 15:05 | 15:05 | |
| 15:10 | 15:10 | |
| 15:15 | 15:15 | |
| 15:20 | 15:20 | |
| 15:25 | 15:25 | |
| 15:30 | 15:30 | |
| 15:35 | 15:35 | |
| 15:40 | 15:40 | |
| 15:45 | 15:45 | |
| 15:50 | 15:50 | |
| 15:55 | 15:55 | |
| 16:00 | 16:00 | |
| 16:05 | 16:05 | |
| 16:10 | 16:10 | |
| 16:15 | 16:15 | |
| 16:20 | 16:20 | |
| 16:25 | 16:25 | |
| 16:30 | 16:30 | |
| 16:35 | 16:35 | |
| 16:40 | 16:40 | |
| 16:45 | 16:45 | |
| 16:50 | 16:50 | |
| 16:55 | 16:55 | |
| 17:00 | 17:00 |